Back
Oryzon Genomics SA Vs. Pharma Mar SA Industry Stock Comparison
Sell
17
ORYZF
Oryzon Genomics SA
Last Price:
1.62
Seasonality Move:
-0.37%
Buy
52
PHMMF
Pharma Mar SA
Last Price:
81.07
Seasonality Move:
13.65%
Sell
17
Oryzon Genomics SA (ORYZF)
is a Sell
Is Oryzon Genomics SA a Buy, Sell or Hold?
- The current Oryzon Genomics SA [ORYZF] share price is $1.62. The Score for ORYZF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- ORYZF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
52
Pharma Mar SA (PHMMF)
is a Buy
Is Pharma Mar SA a Buy, Sell or Hold?
- The current Pharma Mar SA [PHMMF] share price is $81.07. The Score for PHMMF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- PHMMF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ORYZF Stock Price Chart
What is Oryzon Genomics SA's stock price today?
-
The Oryzon Genomics SA share price today is $1.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORYZF is experiencing slight buying pressure.
PHMMF Stock Price Chart
What is Pharma Mar SA's stock price today?
-
The Pharma Mar SA share price today is $81.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHMMF is experiencing slight buying pressure.
ORYZF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 26.07 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.72 - 2) | Sell |
| Bollinger Bands (100): | (1.55 - 2.01) | Sell |
PHMMF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.43 | Buy |
| Relative Strength Index (14 RSI): | 99.12 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.76 - 77.7) | Buy |
| Bollinger Bands (100): | (37.54 - 72.2) | Buy |
ORYZF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.7 | Sell |
| 20-day SMA: | 1.84 | Sell |
| 50-day SMA: | 1.9 | Sell |
| 200-day SMA: | 1.72 | Sell |
| 8-day EMA: | 1.69 | Sell |
| 20-day EMA: | 1.79 | Sell |
| 50-day EMA: | 1.84 | Sell |
| 200-day EMA: | 1.99 | Sell |
PHMMF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.28 | Buy |
| 20-day SMA: | 75.91 | Buy |
| 50-day SMA: | 70.4 | Buy |
| 200-day SMA: | 43.09 | Buy |
| 8-day EMA: | 78.21 | Buy |
| 20-day EMA: | 76.05 | Buy |
| 50-day EMA: | 69.36 | Buy |
| 200-day EMA: | 50.77 | Buy |
Oryzon Genomics SA Earnings Growth & ORYZF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Pharma Mar SA Earnings Growth & PHMMF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Oryzon Genomics SA Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pharma Mar SA Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||